Table 3.
Currently Available Serological Markers Assessing the Structure of the Extracellular Matrix
Name of protein fragment | ECM component | Reference |
---|---|---|
C1M | MMP-mediated type I collagen degradation | 198 |
C2M | MMP-mediated type II collagen degradation | 56 |
C3M | MMP-mediated type III collagen degradation | 60 |
C4M | MMP-mediated type IV collagen degradation | 197 |
C5M | MMP-mediated type V collagen degradation | 331 |
C6M | MMP-mediated type VI collagen degradation | 200 |
P1NP | Type I collagen formation in tissues other than bone | 144 |
P4NP 7S | Type IV collagen formation | 196 |
P5CP | Type V collagen formation | 199 |
PIIANP | Type II collagen formation | 332,333 |
PIIINP | Type III collagen formation | 334 |
VICM | MMP-mediated citrullinated vimentin degradation | 335 |
CRPM | MMP-mediated CRP degradation | 274 |
ELM | MMP-mediated elastin degradation | 217 |
BGM | MMP-mediated biglycan degradation | 336 |
MIM | MMP-mediated mimican degradation | 129 |
VCANM | MMP-mediated versican degradation | 337 |
TIM | MMP-mediated titin degradation | 338 |
Aggrecan | MMP- and aggrenase-cleaved aggrecan | 278 |
COMP | Intact COMP | 339 |
Osteocalcin | Intact osteocalcin bone formation | 340 |
HA | Hyalonic acid | 334 |
ICTP | MMP-mediated type I collagen destruction | 314 |
CTX-I | Cathepsin K degraded type I collagen | 276,311,341,342 |
CTX-II | MMP-degraded type II collagen | 343,344 |
C2C | MMP-degraded type II collagen | 345 |
TELO-I | Citrullinated carboxyterminal telopeptides of type I collagen | 346 |
TELO-II | Citrullinated carboxyterminal telopeptides of type II collagen | 346 |
MCV | Mutated citrullinated vimentin | 347 |
ECM, extracellular matrix; MMP, matrix metalloproteinase; CRP, C-reactive protein.